SCHEMBL5585459

SCHEMBL5585459

CC(C)N(c1ccc(C(=O)O)cc1)c1nc(-c2ccc(NC(=O)c3ccc(C4CCCCC4)cc3)cc2)cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
DEGS1 O15121 1/20 0.46
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPK1 P28482 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585817 0.91 HDAC3 (0.45) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585481 0.89 HDAC3 (0.43) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585769 0.89 HDAC3 (0.43) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585697 0.89 HDAC3 (0.51) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL6000463 0.89 HDAC3 (0.51) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585442 0.88 GRM1 (0.42) NPC1RAB9AKDM4EALDH1A1MEN1
SCHEMBL5585930 0.88 HDAC3 (0.46) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585478 0.88 MRE11 (0.39) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL5585637 0.88 HDAC3 (0.43) HDAC3HDAC11HDAC8HDAC6DEGS1
SCHEMBL5585589 0.87 HDAC3 (0.49) HDAC3HDAC11HDAC8HDAC6DEGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7163952-B2 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2007-01-16 US disclosed
US-7163952-B2 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2007-01-16 US disclosed
US-7163952-B2 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2007-01-16 US disclosed
US-20050065196-A1 Azole compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-24 US disclosed
EP-1452530-A1 AZOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065196-A1 Azole compound and medicinal use thereof PTPN7, PTPN1, PTPN5 HDAC3 1288/4885HDAC11 500/4885HDAC8 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.